Literature DB >> 33007379

Survival benefits of PARP inhibitors in advanced breast cancer: a mirage?

T Grinda1, S Delaloge2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33007379     DOI： 10.1016/j.annonc.2020.09.018

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer.

Authors:  Diar Aziz; Christine Lee; Venessa Chin; Kristine J Fernandez; Zoe Phan; Paul Waring; C Elizabeth Caldon
Journal:  J Pathol Clin Res       Date:  2022-04-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.